Mitigating cognitive side effects associated with topiramate.
Antai-Otong
Deborah
D
Deborah.Antai-otong@med.va.gov
D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects*; D001923:Brain Chemistry / Q000187:drug effects; D003072:Cognition Disorders / Q000139:chemically induced*; D004334:Drug Administration Schedule; D016903:Drug Monitoring / Q000379:methods; D005632:Fructose / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives*; D006801:Humans; D008569:Memory Disorders / Q000139:chemically induced*; D019964:Mood Disorders / Q000175:diagnosis / Q000188:drug therapy; D009446:Neurobiology; D011569:Psychiatric Status Rating Scales; D000077236:Topiramate
D000927:Anticonvulsants; D000077236:Topiramate; D005632:Fructose